Literature DB >> 3580572

Development of large numbers of mast cells at sites of idiopathic chronic dermatitis in genetically mast cell-deficient WBB6F1-W/Wv mice.

S J Galli, N Arizono, T Murakami, A M Dvorak, J G Fox.   

Abstract

The normal skin and other tissues of adult mast cell-deficient WBB6F1-W/Wv or WCB6F1-Sl/Sld mice contain less than 1.0% the number of mast cells present in the corresponding tissues of the congenic normal (+/+) mice. As a result, genetically mast cell-deficient WBB6F1-W/Wv or WCB6F1-Sl/Sld mice are widely used for studies of mast cell differentiation and function. We found that mast cells developed at sites of idiopathic chronic dermatitis in WBB6F1-W/Wv mice and that the number of mast cells present in the skin of WBB6F1-W/Wv mice was proportional to the severity of the dermatitis (in ear skin, there were 33 +/- 4 mast cells/mm2 of dermis at sites of severe dermatitis v 9 +/- 3 at sites of mild dermatitis, 0.8 +/- 0.3 in skin without dermatitis, and 100 +/- 7 in the normal skin of congenic WBB6F1-+/+ mice; in back skin, the corresponding values were 2.0 +/- 0.6, 1.1 +/- 0.9, 0.025 +/- 0.025, and 26.2 +/- 3.2). The development of mast cells was a local, not systemic, consequence of the dermatitis. Thus, WBB6F1-W/Wv mice with severe dermatitis lacked mast cells in skin not showing signs of dermatitis and also in the peritoneal cavity, stomach, cecum, and tongue. Idiopathic chronic dermatitis was not associated with the local development of mast cells in WCB6F1-Sl/Sld mice, a mutant whose mast cell deficiency is due to a mechanism distinct from that of WBB6F1-W/Wv mice. These findings may have implications for understanding the nature of the mast cell deficiency in WBB6F1-W/Wv and WCB6F1-Sl/Sld mice and for the use of these mutants to analyze mast cell differentiation and function.

Entities:  

Mesh:

Year:  1987        PMID: 3580572

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Differences in the Importance of Mast Cells, Basophils, IgE, and IgG versus That of CD4+ T Cells and ILC2 Cells in Primary and Secondary Immunity to Strongyloides venezuelensis.

Authors:  Kaori Mukai; Hajime Karasuyama; Kenji Kabashima; Masato Kubo; Stephen J Galli
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

2.  Role of mast cells in anaphylaxis. Evidence for the importance of mast cells in the cardiopulmonary alterations and death induced by anti-IgE in mice.

Authors:  T R Martin; S J Galli; I M Katona; J M Drazen
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

Review 3.  Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing.

Authors:  Jeffrey Douaiher; Julien Succar; Luca Lancerotto; Michael F Gurish; Dennis P Orgill; Matthew J Hamilton; Steven A Krilis; Richard L Stevens
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

4.  In vitro duplication and in vivo cure of mast-cell deficiency of Sl/Sld mutant mice by cloned 3T3 fibroblasts.

Authors:  J Fujita; H Onoue; Y Ebi; H Nakayama; Y Kanakura
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

5.  Systemic anaphylaxis in the mouse can be mediated largely through IgG1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis.

Authors:  I Miyajima; D Dombrowicz; T R Martin; J V Ravetch; J P Kinet; S J Galli
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

6.  Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains.

Authors:  D Dombrowicz; V Flamand; I Miyajima; J V Ravetch; S J Galli; J P Kinet
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

Review 7.  The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others.

Authors:  S J Galli; M Tsai; B K Wershil
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

8.  Effects of chronic treatment with the c-kit ligand, stem cell factor, on immunoglobulin E-dependent anaphylaxis in mice. Genetically mast cell-deficient Sl/Sld mice acquire anaphylactic responsiveness, but the congenic normal mice do not exhibit augmented responses.

Authors:  A Ando; T R Martin; S J Galli
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice.

Authors:  H HogenEsch; M J Gijbels; E Offerman; J van Hooft; D W van Bekkum; C Zurcher
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

10.  The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis.

Authors:  A Iemura; M Tsai; A Ando; B K Wershil; S J Galli
Journal:  Am J Pathol       Date:  1994-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.